Company: SOS
Filing Date: 2025-07-31
Form Type: 424B5
Source: 0001213900-25-069766
Chunk: 4

Company: SOS Ltd
Filing Date: 2025-07-31
Form: 424B5
Chunk 4
---
 Kong, however, recent
developments with respect to audits of China-based companies create uncertainty about the ability of our PRC subsidiaries to fully cooperate
with Audit Alliance’s audit without the approval of the Chinese authorities. In the event it is later determined that the PCAOB
is unable to inspect or investigate completely our auditor, then such lack of inspection could cause trading in our securities to be prohibited
under the HFCA Act, and ultimately result in a determination by a securities exchange to delist our securities. On August 26, 2022, the
PCAOB signed a Statement of Protocol (the “SOP”) Agreement with the CSRC and China’s Ministry of Finance. The SOP Agreement,
together with two protocol agreements (collectively, “SOP Agreements”), governs inspections and investigations of audit firms
based in mainland China and Hong Kong, taking the first step toward opening access for the PCAOB to inspect and investigate registered
public accounting firms headquartered in mainland China and Hong Kong. Pursuant to the fact sheet with respect to the Protocol disclosed
by the U.S. Securities and Exchange Commission (the “SEC”), the PCAOB shall have independent discretion to select any issuer
audits for inspection or investigation and has the unfettered ability to transfer information to the SEC. On December 15, 2022, the PCAOB
Board determined that the PCAOB was able to secure complete access to inspect and investigate registered public accounting firms headquartered
in mainland China and Hong Kong and voted to vacate its previous determinations to the contrary. However, should PRC authorities obstruct
or otherwise fail to facilitate the PCAOB’s access in the future, the PCAOB Board will consider the need to issue a new determination.

These
risks, if materialized, could result in a material adverse change in our operations and the value of our ADSs, significantly limit or
completely hinder our ability to continue to offer securities to investors, or cause the value of such securities to significantly decline
or be worthless. For more details, see “Item 3. Key Information—D. Risk Factors—Risks Related to Doing Business in China.”
in our 2024 Annual Report.

Investing in our securities involves a high degree of risk. You should purchase our securities only if you can afford a complete loss of your investment. See “Risk Factors” beginning on page S-6 of this prospectus supplement and on page 18 of the accompanying prospectus.

Neither the Securities and Exchange Commission nor any state